How many skin barriers haveth we: Percutaneous egression of ions?


Journal

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)
ISSN: 1600-0846
Titre abrégé: Skin Res Technol
Pays: England
ID NLM: 9504453

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 20 08 2021
accepted: 17 10 2021
pubmed: 10 11 2021
medline: 26 3 2022
entrez: 9 11 2021
Statut: ppublish

Résumé

Skin provides critical barrier properties that enable terrestrial life. Myriad research has focused on the "water barrier" to transepidermal water loss (TEWL) despite there being a multitude of skin barrier properties. We asked what other barrier properties may have been overlooked and compiled data demonstrating the "electrolyte barrier" to be of potential clinical relevance. A literature search was conducted through PubMed, Embase, Google Scholar, and Web of Science databases for the following keywords: "transepidermal" or "epidermal" or "cutaneous" or "skin" or "percutaneous" and "ion" or "sodium" or "chloride" or "potassium" or "electrolyte" and "flux" or "egression." Textbooks at the University of California, San Francisco were also hand reviewed. Experimental studies quantifying in vivo or ex vivo percutaneous egression of ions in response to human skin barrier perturbation were included. Experimental damage to skin, mostly by tape-stripping, frequently induced increased ion flux rates through the epidermis, in addition to increases in TEWL values. Interestingly, barrier perturbation did not always result in a concomitant rise in TEWL and transepidermal ion flux rates, such as in delipidization, indicating a distinction between the two barriers. Quantifying the percutaneous egression of ions in response to physical or chemical alterations may offer additional data that are not to be captured with TEWL studies exclusively. Continued efforts should be made to: (1) advance this technique as a method of assessing skin status and (2) enhance our understanding of other barriers and mechanisms.

Identifiants

pubmed: 34751477
doi: 10.1111/srt.13119
pmc: PMC9907618
doi:

Substances chimiques

Water 059QF0KO0R

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

382-387

Informations de copyright

© 2021 The Authors. Skin Research and Technology published by John Wiley & Sons Ltd.

Références

J Cell Biol. 1975 Apr;65(1):180-91
pubmed: 1127009
J Invest Dermatol. 1953 Oct;21(4):259-71
pubmed: 13096868
Br J Dermatol. 1973 May;88(5):459-63
pubmed: 4715123
J Invest Dermatol. 2013 May;133(5):1161-9
pubmed: 23407391
Skin Res Technol. 2022 Mar;28(2):382-387
pubmed: 34751477
Biochem Soc Trans. 2015 Oct;43(5):1033-40
pubmed: 26517919
Dermatologica. 1990;180(2):66-8
pubmed: 2311797
Toxicol In Vitro. 2018 Sep;51:129-135
pubmed: 29698667
Tissue Barriers. 2015 Apr 03;3(1-2):e974451
pubmed: 25838981
Br J Dermatol. 1981 Jul;105(1):39-44
pubmed: 7259977
J Appl Toxicol. 2009 Oct;29(7):551-9
pubmed: 19629956
Pharmacol Ther. 1981;13(2):357-83
pubmed: 6169098
Biol Neonate. 1977;32(3-4):177-82
pubmed: 603802
Clin Transl Med. 2013 Jun 17;2:12
pubmed: 23773261
J Invest Dermatol. 1981 Apr;76(4):297-301
pubmed: 7205031
Cutan Ocul Toxicol. 2012 Mar;31(1):1-6
pubmed: 21978285
J Anat. 1973 Jan;114(Pt 1):65-81
pubmed: 4736654
Nat Rev Drug Discov. 2010 Mar;9(3):215-36
pubmed: 20190787
Br J Dermatol. 1975 May;92(5):511-8
pubmed: 240374
Skin Pharmacol Physiol. 2008;21(6):294-9
pubmed: 18679045
Exp Dermatol. 2006 Jul;15(7):483-92
pubmed: 16761956
J Invest Dermatol. 1966 Jan;46(1):16-23
pubmed: 5910974
Physiol Rev. 1957 Jul;37(3):325-36
pubmed: 13465317
Anal Bioanal Chem. 2021 Mar;413(7):1883-1891
pubmed: 33479820

Auteurs

Chavy Chiang (C)

School of Medicine and Dentistry, University of Rochester, Rochester, New York, USA.

Howard I Maibach (HI)

Department of Dermatology, University of California, San Francisco, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH